Deutsche Bank Aktiengesellschaft »

Trevi Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2024-03-31 $62k 18k 3.45
2023-09-30 $55k 25k 2.18